|
Beijing Tiantan Biological Products Co., Ltd. (600161.SS) DCF Valuation
CN | Healthcare | Biotechnology | SHH
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Beijing Tiantan Biological Products Co., Ltd. (600161.SS) Bundle
Explore the financial outlook of Beijing Tiantan Biological Products Co., Ltd. (600161SS) with our user-friendly DCF Calculator! Enter your projections for growth, margins, and expenses to calculate the intrinsic value of Beijing Tiantan Biological Products Co., Ltd. (600161SS) and refine your investment strategy.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,281.9 | 3,445.6 | 4,112.2 | 4,261.3 | 5,180.4 | 5,821.9 | 6,542.8 | 7,353.0 | 8,263.5 | 9,286.8 |
| Revenue Growth, % | 0 | 4.99 | 19.35 | 3.63 | 21.57 | 12.38 | 12.38 | 12.38 | 12.38 | 12.38 |
| EBITDA | 1,179.2 | 1,251.3 | 1,409.4 | 1,622.5 | 2,070.3 | 2,149.0 | 2,415.1 | 2,714.2 | 3,050.2 | 3,427.9 |
| EBITDA, % | 35.93 | 36.32 | 34.27 | 38.08 | 39.96 | 36.91 | 36.91 | 36.91 | 36.91 | 36.91 |
| Depreciation | 134.8 | 142.2 | 163.6 | 192.1 | 268.0 | 255.0 | 286.5 | 322.0 | 361.9 | 406.7 |
| Depreciation, % | 4.11 | 4.13 | 3.98 | 4.51 | 5.17 | 4.38 | 4.38 | 4.38 | 4.38 | 4.38 |
| EBIT | 1,044.3 | 1,109.1 | 1,245.8 | 1,430.4 | 1,802.3 | 1,894.0 | 2,128.6 | 2,392.1 | 2,688.3 | 3,021.2 |
| EBIT, % | 31.82 | 32.19 | 30.3 | 33.57 | 34.79 | 32.53 | 32.53 | 32.53 | 32.53 | 32.53 |
| Total Cash | 1,413.4 | 1,748.1 | 4,329.7 | 3,712.9 | 4,554.9 | 4,294.9 | 4,826.7 | 5,424.4 | 6,096.1 | 6,851.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 636.5 | 695.6 | 1,027.3 | 1,200.9 | .0 | 1,079.9 | 1,213.6 | 1,363.9 | 1,532.8 | 1,722.6 |
| Account Receivables, % | 19.39 | 20.19 | 24.98 | 28.18 | 0 | 18.55 | 18.55 | 18.55 | 18.55 | 18.55 |
| Inventories | 1,949.5 | 2,171.9 | 2,144.1 | 2,332.0 | 2,844.5 | 3,309.3 | 3,719.1 | 4,179.6 | 4,697.2 | 5,278.8 |
| Inventories, % | 59.4 | 63.03 | 52.14 | 54.73 | 54.91 | 56.84 | 56.84 | 56.84 | 56.84 | 56.84 |
| Accounts Payable | 49.9 | 45.9 | 73.7 | 69.4 | 179.1 | 113.3 | 127.3 | 143.1 | 160.8 | 180.7 |
| Accounts Payable, % | 1.52 | 1.33 | 1.79 | 1.63 | 3.46 | 1.95 | 1.95 | 1.95 | 1.95 | 1.95 |
| Capital Expenditure | -526.2 | -608.9 | -1,131.7 | -1,354.0 | -1,077.5 | -1,325.1 | -1,489.2 | -1,673.6 | -1,880.8 | -2,113.7 |
| Capital Expenditure, % | -16.03 | -17.67 | -27.52 | -31.77 | -20.8 | -22.76 | -22.76 | -22.76 | -22.76 | -22.76 |
| Tax Rate, % | 38.29 | 38.29 | 38.29 | 38.29 | 38.29 | 38.29 | 38.29 | 38.29 | 38.29 | 38.29 |
| EBITAT | 895.0 | 946.7 | 1,072.9 | 1,208.3 | 1,112.1 | 1,528.0 | 1,717.2 | 1,929.8 | 2,168.8 | 2,437.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2,032.4 | 194.4 | -171.2 | -319.4 | 1,100.8 | -1,152.7 | -14.9 | -16.8 | -18.9 | -21.2 |
| WACC, % | 6.24 | 6.24 | 6.24 | 6.24 | 6.24 | 6.24 | 6.24 | 6.24 | 6.24 | 6.24 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1,142.7 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | -22 | |||||||||
| Terminal Value | -800 | |||||||||
| Present Terminal Value | -591 | |||||||||
| Enterprise Value | -1,734 | |||||||||
| Net Debt | -4,531 | |||||||||
| Equity Value | 2,797 | |||||||||
| Diluted Shares Outstanding, MM | 1,977 | |||||||||
| Equity Value Per Share | 1.41 |
Benefits You Will Enjoy
- Modifiable Forecast Inputs: Effortlessly adjust key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-Time Data: Pre-loaded financial information for Beijing Tiantan Biological Products Co., Ltd. (600161SS) to enhance your analysis.
- Automated DCF Calculations: The template computes Net Present Value (NPV) and intrinsic value automatically for your convenience.
- Tailored and Professional: A sophisticated Excel model designed to fit your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating projections, validating strategies, and increasing efficiency.
Key Features
- 🔍 Real-Life (600161SS) Financials: Pre-filled historical and projected data for Beijing Tiantan Biological Products Co., Ltd.
- ✏️ Fully Customizable Inputs: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Integrated formulas determine the intrinsic value of Beijing Tiantan using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize the valuation of Beijing Tiantan immediately after adjustments.
- Scenario Analysis: Evaluate and compare different outcomes based on various financial assumptions side-by-side.
How It Works
- Download the Template: Gain immediate access to the Excel-based [Symbol] DCF Calculator for Beijing Tiantan Biological Products Co., Ltd.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth projections, WACC, profit margins, and additional parameters.
- Instant Calculations: The model seamlessly updates the intrinsic value of Beijing Tiantan Biological Products Co., Ltd.
- Test Scenarios: Experiment with different assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis decisions.
Why Opt for This Calculator?
- Designed for Experts: A sophisticated tool favored by analysts, CFOs, and consultants.
- Accurate Data: Preloaded historical and forecasted financials for Beijing Tiantan Biological Products Co., Ltd. (600161SS) to ensure precision.
- Scenario Simulation: Effortlessly test various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance helps you navigate through the calculations seamlessly.
Who Should Consider Using This Product?
- Biotechnology Students: Explore advanced bioproduct analysis using real-time data.
- Researchers: Integrate industry-standard models into your studies or publications.
- Investors: Validate your hypotheses and evaluate market performance for Beijing Tiantan Biological Products Co., Ltd. (600161SS).
- Market Analysts: Enhance your efficiency with a customizable financial model tailored for biopharmaceuticals.
- Entrepreneurs in Biotech: Understand the evaluation methods used for large public entities like Beijing Tiantan Biological Products Co., Ltd. (600161SS).
Contents of the Template
- Historical Data: Comprises Beijing Tiantan Biological Products Co., Ltd.'s (600161SS) previous financials and foundational forecasts.
- DCF and Levered DCF Models: Comprehensive templates to evaluate the intrinsic value of Beijing Tiantan Biological Products Co., Ltd. (600161SS).
- WACC Sheet: Pre-constructed calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Adjust essential drivers such as growth rates, EBITDA %, and CAPEX projections.
- Quarterly and Annual Statements: A thorough analysis of Beijing Tiantan Biological Products Co., Ltd.'s (600161SS) financials.
- Interactive Dashboard: Dynamically visualize valuation outcomes and forecasts.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.